CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs). Portfolio includes novel CIMasphere™ technology for higher yielding processes and safer products in AAV-based programs BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development Service, […]

BOULDER, Colo. — InDevR, Inc., a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, today announced that it has raised a $7 million Series A round of equity financing from Adjuvant Capital (“Adjuvant”). The investment from Adjuvant will support research and development activities and allow InDevR to build out a global […]

– For the optimization of operations and training of engineers at Russian refineries – Yokogawa Electric Corporation announces the signing of an agreement with the Public Joint Stock Company Gazprom Neft to establish an International Center for Innovation. The agreement was signed today at a meeting of the Japan Association for Trade with Russia and […]

Univercells and consortium partners Batavia Biosciences and Natrix Separations selected by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries Brussels, Belgium – Univercells announced today that it has been awarded a $12 million grant by the Bill & Melinda Gates Foundation for the development of a breakthrough vaccine manufacturing platform […]

Adds innovative single-use SiusTM TFF technology to downstream bioprocessing portfolio WALTHAM, MA – Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired TangenX Technology Corporation (“TangenX”) of Shrewsbury, MA, maker of the innovative single-use SiusTM line of tangential flow filtration (“TFF”) cassettes and hardware used in downstream biopharmaceutical manufacturing […]

• Biopharma provider purchases property in Science Park III of Ulm • Laboratory and office facility to be constructed on the site by 2019 Göttingen/Laupheim – Sartorius Stedim Cellca based near Ulm in southern Germany, continues on the growth track. At the end of November, the company in its eleventh year since its founding purchased property of […]

DKK-TOA has launched a news range of pH/ORP Meters. New Products Field-installation-type pH Transmitter: HBM-160B ORP Transmitter: HBM-162B Panel-mount type pH Controller: HBM-100B ORP Controller: HBM-102B Features ・2-point Calibration diagnoses the response and the sensitivity of the pH electrode and the integrity of the electrode is displayed ・LCD panel with LED backlight ・CE Marking pH/ORP […]

Andover, Mass. – MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity today announced the introduction of the S49 Thermal Management System. The Series 49 Thermal Management System features a choice of new main heater materials, an advanced heater controller and a simple user interface. Heaters are […]

Santa Clara, California — Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of its new G3Lite+ SmartController for upstream cell culture and fermentation. The G3Lite+ extends the capabilities of Finesse’s G3Lite product for all major brands of single-use bioreactors (50L to 2,000L operating volume) and […]

Accelerates development and manufacture of Acticor’s antibody fragment that treats ischemic stroke Billerica, Massachusetts — MilliporeSigma, today announced that it will provide its Provantage® End-to-Endservices to Acticor Biotech SAS for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke. MilliporeSigma’s Provantage® End-to-End solution is a comprehensive suite of products and services enabling biopharmaceutical […]